BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22094901)

  • 1. Utility of the new ESPGHAN criteria for the diagnosis of celiac disease in at-risk groups.
    Kurppa K; Salminiemi J; Ukkola A; Saavalainen P; Löytynoja K; Laurila K; Collin P; Mäki M; Kaukinen K
    J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):387-91. PubMed ID: 22094901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice.
    Werkstetter KJ; Korponay-Szabó IR; Popp A; Villanacci V; Salemme M; Heilig G; Lillevang ST; Mearin ML; Ribes-Koninckx C; Thomas A; Troncone R; Filipiak B; Mäki M; Gyimesi J; Najafi M; Dolinšek J; Dydensborg Sander S; Auricchio R; Papadopoulou A; Vécsei A; Szitanyi P; Donat E; Nenna R; Alliet P; Penagini F; Garnier-Lengliné H; Castillejo G; Kurppa K; Shamir R; Hauer AC; Smets F; Corujeira S; van Winckel M; Buderus S; Chong S; Husby S; Koletzko S;
    Gastroenterology; 2017 Oct; 153(4):924-935. PubMed ID: 28624578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population.
    Gidrewicz D; Potter K; Trevenen CL; Lyon M; Butzner JD
    Am J Gastroenterol; 2015 May; 110(5):760-7. PubMed ID: 25823767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
    Salmi TT; Collin P; Korponay-Szabó IR; Laurila K; Partanen J; Huhtala H; Király R; Lorand L; Reunala T; Mäki M; Kaukinen K
    Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transglutaminase antibody: usefulness in the diagnosis of celiac disease].
    Palacios Sarrasqueta M ; Rivero Marcotegui A ; SánchezValverde Visus F ; Feijoo Blanco E ; Ramos Arroyo M ; Olivera Olmedo J ; García Merlo S
    An Esp Pediatr; 2000 Dec; 53(6):542-6. PubMed ID: 11148151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celiac disease: the new proposed ESPGHAN diagnostic criteria do work well in a selected population.
    Klapp G; Masip E; Bolonio M; Donat E; Polo B; Ramos D; Ribes-Koninckx C
    J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):251-6. PubMed ID: 23111763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease.
    Koskinen O; Collin P; Lindfors K; Laurila K; Mäki M; Kaukinen K
    J Clin Gastroenterol; 2010 Aug; 44(7):483-8. PubMed ID: 19779364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age.
    Maglio M; Tosco A; Paparo F; Auricchio R; Granata V; Colicchio B; Indolfi V; Miele E; Troncone R
    J Pediatr Gastroenterol Nutr; 2010 Jan; 50(1):43-8. PubMed ID: 19934769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome.
    Wouters J; Weijerman ME; van Furth AM; Schreurs MW; Crusius JB; von Blomberg BM; de Baaij LR; Broers CJ; Gemke RJ
    J Pediatr; 2009 Feb; 154(2):239-42. PubMed ID: 18822429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies.
    Bao F; Yu L; Babu S; Wang T; Hoffenberg EJ; Rewers M; Eisenbarth GS
    J Autoimmun; 1999 Aug; 13(1):143-8. PubMed ID: 10441179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective antibody case finding of coeliac disease in type-1 diabetes children: need of biopsy revisited.
    Popp A; Mihu M; Munteanu M; Ene A; Dutescu M; Colcer F; Raducanu D; Laurila K; Anca I; Mäki M
    Acta Paediatr; 2013 Mar; 102(3):e102-6. PubMed ID: 23211000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coeliac disease diagnosis: ESPGHAN 1990 criteria or need for a change? Results of a questionnaire.
    Ribes-Koninckx C; Mearin ML; Korponay-Szabó IR; Shamir R; Husby S; Ventura A; Branski D; Catassi C; Koletzko S; Mäki M; Troncone R; Zimmer KP;
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):15-9. PubMed ID: 21716133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are ESPGHAN "biopsy-sparing" guidelines for celiac disease also suitable for asymptomatic patients?
    Trovato CM; Montuori M; Anania C; Barbato M; Vestri AR; Guida S; Oliva S; Mainiero F; Cucchiara S; Valitutti F
    Am J Gastroenterol; 2015 Oct; 110(10):1485-9. PubMed ID: 26372508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Celiac disease among children in Finland.
    Mäki M; Mustalahti K; Kokkonen J; Kulmala P; Haapalahti M; Karttunen T; Ilonen J; Laurila K; Dahlbom I; Hansson T; Höpfl P; Knip M
    N Engl J Med; 2003 Jun; 348(25):2517-24. PubMed ID: 12815137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease.
    Donaldson MR; Firth SD; Wimpee H; Leiferman KM; Zone JJ; Horsley W; O'Gorman MA; Jackson WD; Neuhausen SL; Hull CM; Book LS
    Clin Gastroenterol Hepatol; 2007 May; 5(5):567-73. PubMed ID: 17428743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relevance of anti-tissue transglutaminase antibodies in coeliac disease diagnosis].
    Lepers S; Soula F; Fily S; Fontaine E; Vuye S; Colombel JF; Guimber D; Prin L; Dubucquoi S
    Ann Biol Clin (Paris); 2003; 61(3):337-43. PubMed ID: 12805013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests.
    Akbari MR; Mohammadkhani A; Fakheri H; Javad Zahedi M; Shahbazkhani B; Nouraie M; Sotoudeh M; Shakeri R; Malekzadeh R
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1181-6. PubMed ID: 17033439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening.
    Webb C; Norström F; Myléus A; Ivarsson A; Halvarsson B; Högberg L; Lagerqvist C; Rosén A; Sandström O; Stenhammar L; Carlsson A
    J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):787-91. PubMed ID: 25564816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific celiac disease antibodies in children on a gluten-free diet.
    Hogen Esch CE; Wolters VM; Gerritsen SA; Putter H; von Blomberg BM; van Hoogstraten IM; Houwen RH; van der Lely N; Mearin ML
    Pediatrics; 2011 Sep; 128(3):547-52. PubMed ID: 21859913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease.
    Husby S; Koletzko S; Korponay-Szabó IR; Mearin ML; Phillips A; Shamir R; Troncone R; Giersiepen K; Branski D; Catassi C; Lelgeman M; Mäki M; Ribes-Koninckx C; Ventura A; Zimmer KP; ; ;
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):136-60. PubMed ID: 22197856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.